Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients

Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients

The aim of this pilot clinical trial was to evaluate the safety of a new formulation of prolonged-release Pirfenidone (PR-PFD) in chronic kidney disease (CKD), specifically focal and segmental glomerular hyalinization (FSGH). Open-label, pilot, nonrandomized trial. Eighteen patients previously diag...

Full description

Bibliographic Details
Main Authors: Simón A. Ojeda-Duran, Iván Lyra-Gonzalez, Alejandra Meza-Rios, Silvia Lucano-Landeros, Ana Sandoval-Rodriguez, Monica Vazquez-Del Mercado, Arturo Santos, Lucia Flores-Contreras, Juan Armendáriz-Borunda
Format: Article
Language:English
Published: Codon Publications 2020-05-01
Series:Journal of Renal and Hepatic Disorders
Subjects:
Chronic Kidney Disease
glomerular filtration rate
prolonged-released Pirfenidone.
Online Access:https://jrenhep.com/index.php/jrenhep/article/view/61

Internet

https://jrenhep.com/index.php/jrenhep/article/view/61

Similar Items